It is well recognized that the complex pathology of dementias such as AD means it cannot be adequately studied in a single animal model, as they are largely based on a single hypothesis, and usually rely on rare genetic mutations detected in AD (APP, BACE, presenilin) or FTD (tau) patients. This evidence concerns the gene MAPT and Alzheimer disease.